BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23029168)

  • 1. Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis.
    Giri H; Biswas I; Rezaie AR
    J Thromb Haemost; 2023 Jan; 21(1):133-144. PubMed ID: 36695376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis and Inflammation-A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C.
    Kohli S; Shahzad K; Jouppila A; Holthöfer H; Isermann B; Lassila R
    Front Cardiovasc Med; 2022; 9():866751. PubMed ID: 35433860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Protein C Ameliorates Diabetic Cardiomyopathy
    Zhong X; Wang T; Xie Y; Wang M; Zhang W; Dai L; Lai J; Nie X; He X; Madhusudhan T; Zeng H; Wang H
    Front Cardiovasc Med; 2021; 8():758158. PubMed ID: 34778410
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure.
    Balogh V; MacAskill MG; Hadoke PWF; Gray GA; Tavares AAS
    Front Cardiovasc Med; 2021; 8():719031. PubMed ID: 34485416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C protects against pressure overload-induced hypertrophy through AMPK signaling.
    Cates C; Rousselle T; Wang J; Quan N; Wang L; Chen X; Yang L; Rezaie AR; Li J
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2584-2594. PubMed ID: 29287725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.
    Nazir S; Gadi I; Al-Dabet MM; Elwakiel A; Kohli S; Ghosh S; Manoharan J; Ranjan S; Bock F; Braun-Dullaeus RC; Esmon CT; Huber TB; Camerer E; Dockendorff C; Griffin JH; Isermann B; Shahzad K
    Blood; 2017 Dec; 130(24):2664-2677. PubMed ID: 28882883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between blood coagulation markers, NT-proBNP and risk of incident heart failure in older men: The British Regional Heart Study.
    Wannamethee SG; Whincup PH; Papacosta O; Lennon L; Lowe GD
    Int J Cardiol; 2017 Mar; 230():567-571. PubMed ID: 28043678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Thrombomodulin (Solulin) Ameliorates Early Intestinal Radiation Toxicity in a Preclinical Rat Model.
    Pathak R; Wang J; Garg S; Aykin-Burns N; Petersen KU; Hauer-Jensen M
    Radiat Res; 2016 Aug; 186(2):112-20. PubMed ID: 27459702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.
    Xue M; Jackson CJ
    Adv Wound Care (New Rochelle); 2015 Mar; 4(3):119-136. PubMed ID: 25785236
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis.
    Wildhagen KC; Schrijver R; Beckers L; ten Cate H; Reutelingsperger CP; Lutgens E; Nicolaes GA
    PLoS One; 2014; 9(7):e101446. PubMed ID: 25032959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory functions of protein C require RAGE and ICAM-1 in a stimulus-dependent manner.
    Braach N; Buschmann K; Pflaum J; Hudalla H; Koch L; Ryschich E; Poeschl J; Frommhold D
    Mediators Inflamm; 2014; 2014():743678. PubMed ID: 24876676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE controls activation and anti-inflammatory signalling of protein C.
    Braach N; Frommhold D; Buschmann K; Pflaum J; Koch L; Hudalla H; Staudacher K; Wang H; Isermann B; Nawroth P; Poeschl J
    PLoS One; 2014; 9(2):e89422. PubMed ID: 24586767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in mice.
    Sopel MJ; Rosin NL; Falkenham AG; Bezuhly M; Esmon CT; Lee TD; Liwski RS; Légaré JF
    PLoS One; 2012; 7(9):e45663. PubMed ID: 23029168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells.
    Sopel MJ; Rosin NL; Lee TD; Légaré JF
    Lab Invest; 2011 Apr; 91(4):565-78. PubMed ID: 21116240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial migration by fibroblast progenitor cells is blood pressure dependent in a model of angII myocardial fibrosis.
    Rosin NL; Sopel M; Falkenham A; Myers TL; Légaré JF
    Hypertens Res; 2012 Apr; 35(4):449-56. PubMed ID: 22258030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide.
    Chinnakkannu P; Reese C; Gaspar JA; Panneerselvam S; Pleasant-Jenkins D; Mukherjee R; Baicu C; Tourkina E; Hoffman S; Kuppuswamy D
    PLoS One; 2018; 13(12):e0207844. PubMed ID: 30576317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.
    Funck RC; Wilke A; Rupp H; Brilla CG
    Adv Exp Med Biol; 1997; 432():35-44. PubMed ID: 9433509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C: A regulator of human skin epidermal keratinocyte function.
    McKelvey K; Jackson CJ; Xue M
    World J Biol Chem; 2014 May; 5(2):169-79. PubMed ID: 24921007
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.